MOH Stock Analysis: Buy, Sell, or Hold?
MOH - Molina Healthcare, Inc.
$131.47
-2.56 (-1.91%)
▼
5d:
-2.79%
30d:
-14.66%
90d:
-20.24%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 22, 2026
21d
Smart Money Accumulation
MOH is down 4.2% this week, but smart money is accumulating calls. Top strike: $170 2026-04-17 with 228 OI. Call ratio: 64% View Scanner →
Strength: 3.5/10
Get Alerted When MOH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MOH trades at premium valuation expecting 11.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: MOH trades at premium valuation expecting 11.4% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.12
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$72.10
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MOH is currently trading at $131.47, which is considered slightly low relative to its 30-day fair value range of $140.42 to $150.91. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.8) compared to its historical average (16.5). At these levels, the market is pricing in 11.4% annual earnings growth.
Technical Outlook: Technically, MOH is in a strong downtrend. The price is currently testing key support at $131.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MOH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $150.65 (+14.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MOH is in a strong downtrend. The price is currently testing key support at $131.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MOH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $150.65 (+14.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$140.42 -
$150.91
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding MOH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($150.65)
- BULLISH: Expecting earnings turnaround to 11.4% growth with 7.1% revenue growth
Fair Price Analysis
30-Day Fair Range
$140.42 -
$150.91
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$131.46
Resistance Level
$151.28
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.78
Wall Street Target
$150.65
(+14.6%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
-73.4%
Profit Margin
1.1%
Valuation Premium vs History
+11.4% premium
PE vs Historical
22.8 vs 16.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.4%
(market-implied from PE analysis)
1-Year Target
$146.46
(+11%)
2-Year Target
$163.15
(+24%)
3-Year Target
$181.75
(+38%)
3-Yr Target (if PE normalizes)
(PE: 23→17)
PE COMPRESSION
$131.63
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.8, Growth: 4.1%)
$148.46
(+13%)
Base:
(SPY PE: 22.4, Growth: 4.1%)
$145.64
(+11%)
Bear:
(PE: 16.5, Growth: 4.1%)
$107.52
(-18%)
📈
Valuation based on Current Earnings
Trailing PE: 15.63 | Current EPS (TTM): $8.92
Bull Case
$99.21
(-27%)
Analyst growth -35.3%, PE expands to 17.2
Base Case
$90.19
(-33%)
Market implied -35.3%, PE stable at 15.6
Bear Case
$94.80
(-30%)
Severe decline -20.0%, PE contracts to 13.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 31, 2026 12:12 AM ET
Data refreshes hourly during market hours. Next update: 1:12 AM
Data refreshes hourly during market hours. Next update: 1:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOH showing a specific setup today?
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
SELL
2026-02-17
Ro Khanna
SELL
2026-02-05
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$97 | 57 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$339 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$361 | 49 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$381 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$212 | 61 BUY |
Advanced MOH Option Strategies
Professional options setups generated by AI based on today's MOH price and gamma walls.
